
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Shpall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1983 - 1985
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1980 - 1983
University of Cincinnati College of MedicineClass of 1980
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2027
TX State Medical License 2002 - 2027
GA State Medical License 2023 - 2026
LA State Medical License 2023 - 2026
MS State Medical License 2023 - 2026
OK State Medical License 2020 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
Clinical Trials
- Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes Start of enrollment: 2001 Feb 01
- Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor Start of enrollment: 2006 Sep 01
- Cord Blood Expansion on Mesenchymal Stem Cells Start of enrollment: 2007 Jul 03
Publications & Presentations
PubMed
- New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma.Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop
Blood Advances. 2026-01-13 - Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single...Betül Oran, Peter Thall, Amin Alousi, Gheath Al-Atrash, Rohtesh Mehta
Haematologica. 2026-01-01 - Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukemia-A Retrospective, Dual-Center Study.Oren Pasvolsky, Shai Shimony, Rima M Saliba, Curtis Marcoux, Celina Ledesma
American Journal of Hematology. 2026-01-01
Journal Articles
- The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant RecipientsRoy F Chemaly, Elizabeth Shpall, The Journal of Infectious Diseases
- Management Guidelines for Paediatric Patients Receiving Chimeric Antigen Receptor T Cell TherapyKris M Mahadeo, Julie C Fitzgerald, Marie E Steiner, Partow Kebriaei, Katayoun Rezvani, Ira M Cheifetz, John M Slopis, Paul L Martin, Sattva S Neelapu, Agne Tarasevici..., Nature
Abstracts/Posters
- Blinatumomab Is Well Tolerated Maintenance Therapy Following Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic LeukemiaElizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDSElizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Third-Party BK Virus Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following AllotransplantationElizabeth J. Shpall, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Assessment and Management of Cytokine Release SyndromeASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
- Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation after Double Cord Blood Transplantation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Manufacture of Clinical-Grade Universal Antigen Presenting Cells (UAPC) for the Ex Vivo Expansion and Activation of Natural Killer (NK) Cells2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
AACR: Researchers Share Promising Results from MD Anderson Clinical TrialsApril 25th, 2025- Top Keywords at TCT in 'Virtual' HawaiiFebruary 16th, 2021
- Genetically Enhanced, Cord-Blood Derived Immune Cells Strike B-cell CancersOctober 23rd, 2020
Grant Support
- Novel Cord Blood-Derived Cellular TherapiesUNIVERSITY OF TX MD ANDERSON CAN CTR2011–2025
- Hematopoietic Progenitor Cells - Cord BloodNational Cancer Institute2010–2012
- GOOD Manufacturing Practice (GMP) And Immune Assessment CoreNational Cancer Institute2010–2011
- Hematopoietic Progenitor CellsNational Cancer Institute2002–2007
- Hematopoietic Progenitor CellsNational Cancer Institute1993–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:














